Form 4: Sotera Health Co Executive Alexander Dimitrief Reports Stock Transactions

Alexander Dimitrief, SVP, General Counsel and Secretary of Sotera Health Co, reports acquisition and disposal of company stock and RSUs.

Summary

• On March 2, 2025, Alexander Dimitrief disposed of 8,211 shares of Common Stock at $12.47 to cover tax obligations related to vesting RSUs.
• On March 3, 2025, Dimitrief acquired 56,053 RSUs.
• Dimitrief also acquired 28,026 performance-based RSUs on March 3, 2025.
• Following these transactions, Dimitrief beneficially owns 334,725 shares of Common Stock and 28,026 performance RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine and reflect standard executive compensation practices. There is no indication of unusual or concerning activity.

Positives

• The acquisition of RSUs and performance-based RSUs suggests confidence in the company's future performance.

Negatives

• The disposal of shares to cover tax obligations, while routine, slightly reduces the executive's direct stock holdings.

Risks

• The vesting of performance-based RSUs is contingent on achieving stock price-related performance conditions, which may not be met.

Future Outlook

The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to vesting conditions. The additional RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Comparison to Industry Standards

• Executive compensation packages often include stock options and RSUs to align management's interests with those of shareholders.
• The vesting schedules and performance conditions associated with the RSUs are typical for incentive plans in publicly traded companies.
• Comparing the size of the RSU grants and stock option holdings to those of executives at comparable companies (e.g., Steris, Medtronic) could provide further context.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders.
• The reporting provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates